Breaking News SKVI: Skinvisible Signs DermSafe Agreement for Europe and China — RHEI Pharmaceuticals Adds Alcohol-Free Hand Sanitizer to its Product Line

Skinvisible, Inc. (OTCBB:SKVI)

StockGuru SKVI Profile

Breaking News SKVI: Skinvisible Signs DermSafe Agreement for Europe and China — RHEI Pharmaceuticals Adds Alcohol-Free Hand Sanitizer to its Product Line

Skinvisible, Inc. (OTCBB:SKVI), the developers of Invisicare, and RHEI Pharmaceuticals HK Ltd. , a Hong Kong-based pharmaceutical company and a subsidiary of Luxembourg-based Leeward Ventures SICAR SCA, have entered into an exclusive licensing agreement for the commercial/institutional rights for DermSafe(R) Hand Sanitizer for Europe and China. The agreement follows the previously announced July 13th licensing agreement with RHEI for three skincare products, including an adult incontinence cream, barrier cream, and super moisturizer.

The agreement includes licensing fees payable in milestones based on regulatory approval in Europe and China, anticipated to occur within twelve months or less. RHEI will pay Skinvisible a royalty on product sales and be responsible for seeking regulatory approval, manufacturing, and commercialization. Skinvisible retains rights to DermSafe for the retail/consumer markets within Europe and China. This agreement also provides Skinvisible with all data generated by RHEI to pursue regulatory approvals within the U.S. and internationally.

“These two new agreements with RHEI represent $1.5 million in licensing fees and on-going royalties on product sales for Skinvisible,” stated Terry Howlett, President and CEO of Skinvisible. “This agreement provides another opportunity for RHEI to leverage its international affiliates with established client lists in Europe and China. It is an important step in accelerating the worldwide commercialization of Invisicare products, and represents the third DermSafe licensing agreement, with previous agreements covering Canada and South East Asia.”

“There is a critical need for a safe and effective hand sanitizer made without alcohol for use in hospital and nursing homes,” said Peter Vanderbruggen, Managing Director, Leeward Ventures SICAR SCA. “We have been very impressed with the clinical studies conducted on DermSafe on bacteria and viruses, including influenza A viruses, C difficile, and MRSA. We are excited to be working with Skinvisible to introduce this innovative product to our customer base, and to help protect healthcare professionals and their patients.”

DermSafe is a unique, patented hand sanitizer, formulated with 4% chlorhexidine gluconate, an active ingredient used safely, internationally, as a pre-surgical scrub and in periodontal products. DermSafe is made without alcohol, and is proven to kill both bacteria and viruses for up to four hours, even with hand washing.

About Skinvisible Pharmaceuticals, Inc.

Skinvisible is a research and development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time, resisting both wash off and perspiration, along with controlling the release of actives, and reducing irritation. Skinvisible receives a combination of research and development fees, license fees, and royalties for the life of the patent. Skinvisible’s value also lies in its ability to continually generate new IP on topical products formulated with Invisicare.


StockGuru is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 – (469) 252-3030. Disclosure: StockGuru entered into an investor relations consulting and market awareness contract on July 12, 2010. The company has agreed to pay us five thousand dollars per month in cash for the period of six months, totaling thirty thousand USD. StockGuru was previously compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending January 30, 2010. To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program. This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. To further clarify, we will not be buying or selling shares for the period of July 12, 2010 through January 12, 2011. We hold no shares and will not be receiving further compensation that is share related during this period. StockGuru is not a registered investment adviser or a broker/dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

[wp-rss-aggregator exclude="125509,69034"]